| Recurrent salivary pleomorphic adenoma shows increased immunohistologic expression of bcl-2 oncoprotein. | None |
| C3a/C3aR signaling during host immune response suppresses Fas expression and caspase-3 activity while increasing Bcl-2 proto-oncogene protein expression, providing protection to myeloid and lymphoid cells against L. monocytogenes-induced apoptosis. | None |
| Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia. | None |
| Data indicate that proto-oncogene proteins c-bcl-2 BH4 domain helices inhibit BCL2-associated X protein BAX at a novel interaction site. | None |
| Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. | None |
| Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras. | None |
| Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes. | None |
| Oncogenic potential of bcl-2 demonstrated by gene transfer. | None |
| Mapping of the bcl-2 oncogene on mouse chromosome 1. | None |
| miR-125a-3p is involved in LukS-PV-mediated cell differentiation and apoptosis by targeting to neurofibromatosis type 1 and Proto-Oncogene Proteins c-bcl-2 | None |
| Authors found that the phenotypic alterations by miR-365 were partially due to downregulation of CCND1 and BCL2 oncogenes. | None |
| Expression of the murine proto-oncogene bcl-2 is stage specific and cell-type specific. | None |
| Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. | None |
| Bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin s disease of the nodular sclerosis subtype. | None |
| Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. | None |
| Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. | None |
| Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. | None |
| Functional similarity between adenovirus E1B 19-kDa protein and proteins encoded by Bcl-2 proto-oncogene and Epstein-Barr virus BHRF1 gene. | None |
| Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein. | None |
| Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. | None |